Intrapleural streptokinase for pleural infection [13]

British Medical Journal

Volumn 332, Issue 7540, 2006, Pages 552-

  Maskell, Nick ^a   Nunn, Andrew ^b   Davies, Robert J O ^c  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; FIBRINOLYTIC AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DATA BASE; DISEASE CLASSIFICATION; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HUMAN; LETTER; LUNG SURGERY; PLEURA EMPYEMA; PLEURA FLUID; PLEURISY; PREVALENCE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; MIDDLE AGED; NOTE; PLEURA EFFUSION;

CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HUMANS; MIDDLE AGED; PLEURAL EFFUSION; STREPTOKINASE; TREATMENT OUTCOME;

EID: 33644878870     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Bourns D, Antoniou K, Light RW Intrapleural streptokinase for pleural infection. BMJ 2006;332:133-4.
2. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Eng J Med 2005;352:865-74.
3. Davies RJ, Triall ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
4. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Resp Crit Care Med 2004;70:49-53.
5. Bouros D, Schiza, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. Am J Resp Crit Care Med 1999;159:37-42.